National Pharmacy Health & Leadership Alliance Verify a MemberMember Login

What changed today in Aesthetics & Longevity: 3 new studies

Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.

The signal

NPHLA tracked 3 new official records on this desk today: 3 new studies.

Why this matters

New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.

What changed

  1. New research in Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]: “Platelet-Rich Plasma and Platelet-Based Products in Facial Rejuvenation: State of the Evidence in Skin Quality, Periorbital Aesthetics, and Soft Tissue Augmentation”.[1]
  2. New research in Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]: “Combination Therapy of Injectables With Energy-Based Treatments for Facial Rejuvenation: An Updated Review”.[2]
  3. New research in Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]: “The FDA-Approved and Non-FDA-Approved Indications for Biostimulatory Fillers off the Face”.[3]
  4. Also reported by Dermatology Times: “JAK Inhibitors in Alopecia Areata: Treatment Goals, Safety Data, and Long-Term Management”.[4]
  5. Also reported by Dermatology Times: “Case 3: Alopecia Areata with Facial Involvement”.[5]

Who this affects

  • Med spas
  • Medical directors
  • Prescribers
  • Practice owners & operators
  • Pharmacies

What to watch next

No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.

NPHLA takeaway

These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.

Source file

  1. [1]
  2. [2]
    Combination Therapy of Injectables With Energy-Based Treatments for Facial Rejuvenation: An Updated Review (opens the source in a new tab)

    Peer reviewedDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

  3. [3]
    The FDA-Approved and Non-FDA-Approved Indications for Biostimulatory Fillers off the Face (opens the source in a new tab)

    Peer reviewedDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

  4. [4]
    JAK Inhibitors in Alopecia Areata: Treatment Goals, Safety Data, and Long-Term Management (opens the source in a new tab)

    News reportingDermatology TimesIndustry coverage — headline and link only

  5. [5]
    Case 3: Alopecia Areata with Facial Involvement (opens the source in a new tab)

    News reportingDermatology TimesIndustry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.